SYMBICORT is a registered trademark of the AstraZeneca group of companies.
©2009 AstraZeneca LP. All rights reserved. 278586 3/09
їїЖ С о Ж )© С іКьО р o f f
•YM B0@ ©ETf
0
C
ü û s c ü
E Ç 7 а а Ж п ш і
t e
Ш Ш Ш
Q S Πffio O
It helps c o n tro l m y asthm a sym pto m s day and nig ht
9
and starts o p e n in g m y airw ays w ith in 15 m in u te s.*
Im portantly, SYM BICO RT w o n ’t rep lace a rescue
inh aler fo r su d d e n sym ptom s.
A n d SYM BICO RT co m b in e s tw o m ed icin es to help
co n tro l inflam m ation and co n strictio n . So I’m
b re ath in g m ore freely, and th a t fe e ls g o o d to me.
If your asthma symptoms keep coming back,
ask your health care professional if SYMBICORT
is right for you.
*Your results may vary.
IMPORTANT SAFETY INFORMATION
Prescription SYMBICORT is a controller medicine for the long-term
maintenance treatment of asthma. SYMBICORT is for people 12
years and older whose doctor has decided are not well controlled
on another asthma-controller medicine or who need two asthma-
controller medicines. SYMBICORT is not for the treatment of sudden
asthma symptoms.
SYMBICORT contains formoterol, a long-acting beta2-agonist
(LABA). Medicines containing LABAs may increase the chance
of asthma-related death. So, SYMBICORT should be used only if
your health care professional decides another asthma-controller
medicine alone does not control your asthma or you need two
controller medicines.
While taking SYMBICORT, never use another medicine containing a LABA.
SYMBICORT won’t replace rescue inhalers for sudden asthma
symptoms. Do not use SYMBICORT more than twice a day.
If you are taking SYMBICORT, see your health care professional if
your asthma does not improve or gets worse.
Some people may experience increased blood pressure, heart
rate, or change in heart rhythm. Tell your doctor if you have a heart
condition or high blood pressure. If you are switching to SYMBICORT
from an oral corticosteroid, follow your doctor’s instructions to avoid
health risks when you stop using oral corticosteroids.
Avoid exposure to infections such as chicken pox or measles.
Tell your health care professional immediately if you are exposed.
In clinical studies, common side effects included nose and throat
irritation, headache, upper respiratory tract infection, sore throat,
sinusitis, and stomach discomfort.
Please see Important Product Information on adjacent page and
discuss with your doctor.
You ore encouraged to report negative side effects of prescription
drugs to the FDA. Visit www.fdo.gov/medwotch, or coll 1-800-FDA-1088.
For more information, go to MySymbicort.com
or call 1-888-777-4350.
If y o u c a n n o t a ffo rd y o u r p re scrip tio n ,
A s tra Z e n e c a m a y b e a b le to h elp.
Syrhbicort
(budesonide/formoterol fumarate dihydrate)
Inhalation Aerosol
AstraZeneca"^
